Effects of SGLT2i in the perioperative care of cardiac surgery: a systematic review and meta-analysis of randomised controlled trials
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated cardiovascular and renal protective effects in patients with heart failure and chronic kidney disease, beyond their glucose-lowering properties. In the perioperative setting of cardiac surgery, patients are at increased risk of complications suc...